Search for Clinical Trial Results

Sponsored By

Philadelphia Chromosome - 23 Studies Found

Status Study
Completed Study Name: A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Condition: Myelogenous Leukemia, Chronic
Date: 2012-01-01
Interventions:
  • Drug: flumatinib Flumatinib wa
Completed Study Name: Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
Condition: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Date: 2026-01-10
Interventions: Ancillary studies
COMPLETED Study Name: A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Condition: Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
Date: 2026-01-10
Interventions: Ponatinib tablets.
<<< Previous